{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T08:03:37Z","timestamp":1744013017970},"reference-count":42,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.vaccine.2012.06.006","type":"journal-article","created":{"date-parts":[[2012,6,18]],"date-time":"2012-06-18T05:32:32Z","timestamp":1339997552000},"page":"5229-5234","source":"Crossref","is-referenced-by-count":15,"title":["Monitoring adverse events following immunization with a new conjugate vaccine against group A meningococcus in Niger, September 2010"],"prefix":"10.1016","volume":"30","author":[{"given":"Maman S.","family":"Chaibou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harouna","family":"Bako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laouali","family":"Salisou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T\u00e9n\u00e9 M.","family":"Yam\u00e9ogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariama","family":"Sambo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoudou H.","family":"Djingarey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick L.F.","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Perea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Pezzoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"July (4)","key":"10.1016\/j.vaccine.2012.06.006_bib0005","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0035-9203(99)90106-2","article-title":"Manson Lecture. Meningococcal meningitis in Africa","volume":"93","author":"Greenwood","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2012.06.006_bib0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3855\/jidc.193","article-title":"Control of meningococcal meningitis outbreaks in sub-Saharan Africa","volume":"2","author":"Chippaux","year":"2008","journal-title":"J Infect Dev Ctries"},{"issue":"19 February (8)","key":"10.1016\/j.vaccine.2012.06.006_bib0015","first-page":"47","article-title":"Meningitis in Chad, Niger and Nigeria: 2009 epidemic season","volume":"85","author":"World Health Organization","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"issue":"3 September (Suppl 1)","key":"10.1016\/j.vaccine.2012.06.006_bib0020","doi-asserted-by":"crossref","first-page":"A97","DOI":"10.1016\/j.vaccine.2007.04.049","article-title":"The meningitis vaccine project","volume":"25","author":"LaForce","year":"2007","journal-title":"Vaccine"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.06.006_bib0025","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1377\/hlthaff.2011.0295","article-title":"Product development partnerships hit their stride: lessons from developing a meningitis vaccine for Africa","volume":"30","author":"Bishai","year":"2011","journal-title":"Health Aff (Millwood)"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.06.006_bib0030","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1377\/hlthaff.2011.0328","article-title":"Eliminating epidemic group a meningococcal meningitis in Africa through a new vaccine","volume":"30","author":"LaForce","year":"2011","journal-title":"Health Aff (Millwood)"},{"issue":"32","key":"10.1016\/j.vaccine.2012.06.006_bib0035","first-page":"325","article-title":"Global Advisory Committee on vaccine safety, report of meeting held 16\u201317 June 2010","volume":"84","author":"World Health Organization","year":"2010","journal-title":"Wkly Epidemiol Rec"},{"issue":"30 April (Suppl 2)","key":"10.1016\/j.vaccine.2012.06.006_bib0040","doi-asserted-by":"crossref","first-page":"B46","DOI":"10.1016\/j.vaccine.2011.12.112","article-title":"Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010","volume":"30","author":"Ouandaogo","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.06.006_bib0045","doi-asserted-by":"crossref","first-page":"e29116","DOI":"10.1371\/journal.pone.0029116","article-title":"Whom and where are we not vaccinating? Coverage after the Introduction of a new conjugate vaccine against Group A meningococcus in Niger in 2010","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"issue":"16 June (24)","key":"10.1016\/j.vaccine.2012.06.006_bib0050","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1003812","article-title":"Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans","volume":"364","author":"Sow","year":"2011","journal-title":"N Engl J Med"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2012.06.006_bib0055","first-page":"705","article-title":"Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS","volume":"8","author":"Global Advisory Committee on Vaccine Safety, World Health Organization","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"7 October (9237)","key":"10.1016\/j.vaccine.2012.06.006_bib0060","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","article-title":"Adverse drug reactions: definitions, diagnosis, and management","volume":"356","author":"Edwards","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.06.006_bib0215","unstructured":"Kohl KS, Bonhoeffer J, Braun MM, Chen RT, Duclos P, Heijbel H, et al. The Brighton Collaboration: creating a global standard for case definitions (and guidelines) for adverse events following immunization. In: Henriksen K, Battles JB, Marks ES, Lewin DI, editors. Advances in Patient Safety: From Research to Implementation (Volume 2: Concepts and Methodology). Rockville (MD): Agency for Healthcare Research and Quality (US); 2005 February."},{"issue":"August (4)","key":"10.1016\/j.vaccine.2012.06.006_bib0070","first-page":"320","article-title":"Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations","volume":"69","author":"Yameogo","year":"2009","journal-title":"Med Trop (Mars)"},{"issue":"3 September (Suppl 1)","key":"10.1016\/j.vaccine.2012.06.006_bib0075","doi-asserted-by":"crossref","first-page":"A72","DOI":"10.1016\/j.vaccine.2007.04.045","article-title":"Monitoring of adverse events during the 2003 mass vaccination campaign with a trivalent meningococcal A\/C\/W135 polysaccharide vaccine in Burkina Faso","volume":"25","author":"Bentsi-Enchill","year":"2007","journal-title":"Vaccine"},{"issue":"6 April (16)","key":"10.1016\/j.vaccine.2012.06.006_bib0080","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.vaccine.2008.11.036","article-title":"Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies","volume":"27","author":"Bonhoeffer","year":"2009","journal-title":"Vaccine"},{"issue":"6 April (16)","key":"10.1016\/j.vaccine.2012.06.006_bib0085","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.vaccine.2008.11.035","article-title":"Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems","volume":"27","author":"Bonhoeffer","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2012.06.006_bib0090","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF03256199","article-title":"Review of national spontaneous reporting schemes. Strengths and weaknesses","volume":"21","author":"Hughes","year":"2002","journal-title":"Adverse Drug React Toxicol Rev"},{"issue":"25 November (2)","key":"10.1016\/j.vaccine.2012.06.006_bib0095","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.vaccine.2004.05.018","article-title":"Safety of the yellow fever vaccine during the September 2001 mass vaccination campaign in Abidjan Ivory Coast","volume":"23","author":"Fitzner","year":"2004","journal-title":"Vaccine"},{"issue":"23 March (12)","key":"10.1016\/j.vaccine.2012.06.006_bib0100","first-page":"85","article-title":"Causality assessment of adverse events following immunization","volume":"76","author":"World Health Organization","year":"2001","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2012.06.006_bib0105","unstructured":"World Health Organization. Training on monitoring and management of adverse events following immunization. 5-9-2005. 17-5-2012. Ref Type: Online Source."},{"key":"10.1016\/j.vaccine.2012.06.006_bib0110","unstructured":"EpiInfo 2000 [computer program]; 2004."},{"issue":"July (4)","key":"10.1016\/j.vaccine.2012.06.006_bib0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4161\/hv.1.4.2018","article-title":"Group C meningococcal polysaccharide-tetanus toxoid conjugate vaccine: a meta-analysis of immunogenicity, safety and posology","volume":"1","author":"Pollabauer","year":"2005","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2012.06.006_bib0120","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/1471-2458-11-389","article-title":"Health care seeking behavior for diarrhea in children under 5 in rural Niger: results of a cross-sectional survey","volume":"11","author":"Page","year":"2011","journal-title":"BMC Public Health"},{"issue":"3 November (43)","key":"10.1016\/j.vaccine.2012.06.006_bib0125","first-page":"1172","article-title":"Nutritional and health status of children during a food crisis\u2014Niger, September 17\u2013October 14, 2005","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1 February (3)","key":"10.1016\/j.vaccine.2012.06.006_bib0130","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1086\/499240","article-title":"Case-fatality rate during a measles outbreak in eastern Niger in 2003","volume":"42","author":"Nandy","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2012.06.006_bib0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4161\/hv.3.2.3878","article-title":"Post-licensure safety of the meningococcal group C conjugate vaccine","volume":"3","author":"Andrews","year":"2007","journal-title":"Hum Vaccin"},{"issue":"23 November (8778)","key":"10.1016\/j.vaccine.2012.06.006_bib0140","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/0140-6736(91)92592-P","article-title":"Epidemiological basis for clinical diagnosis of childhood malaria in endemic zone in West Africa","volume":"338","author":"Rougemont","year":"1991","journal-title":"Lancet"},{"issue":"22 July (30)","key":"10.1016\/j.vaccine.2012.06.006_bib0145","first-page":"321","article-title":"Meeting of the Global Advisory Committee on Vaccine Safety June 2011","volume":"86","author":"World Health Organization","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"issue":"9 April (15\u201316)","key":"10.1016\/j.vaccine.2012.06.006_bib0150","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/S0264-410X(98)00410-1","article-title":"Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents","volume":"17","author":"Mark","year":"1999","journal-title":"Vaccine"},{"issue":"15 May (Suppl 1)","key":"10.1016\/j.vaccine.2012.06.006_bib0155","doi-asserted-by":"crossref","first-page":"S299","DOI":"10.1086\/368227","article-title":"Ensuring injection safety during measles immunization campaigns: more than auto-disable syringes and safety boxes","volume":"187","author":"Hersh","year":"2003","journal-title":"J Infect Dis"},{"issue":"15 May (Suppl 1)","key":"10.1016\/j.vaccine.2012.06.006_bib0160","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1086\/368049","article-title":"Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues","volume":"187","author":"Pless","year":"2003","journal-title":"J Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.06.006_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1473-3099(10)70300-5","article-title":"A vaccine against meningitis in Africa","volume":"11","author":"Lancet Infectious Diseases","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2012.06.006_bib0170","series-title":"Infectious disease surveillance","first-page":"241","article-title":"Vaccine preventable diseases. Part 2: Public health surveillance for vaccine adverse events","author":"Iskander","year":"2007"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.06.006_bib0175","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2105\/AJPH.85.12.1706","article-title":"The reporting sensitivities of two passive surveillance systems for vaccine adverse events","volume":"85","author":"Rosenthal","year":"1995","journal-title":"Am J Public Health"},{"issue":"19 June (26)","key":"10.1016\/j.vaccine.2012.06.006_bib0180","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.vaccine.2008.03.074","article-title":"Comparison of epidemiologic methods for active surveillance of vaccine safety","volume":"26","author":"McClure","year":"2008","journal-title":"Vaccine"},{"issue":"1 April (4)","key":"10.1016\/j.vaccine.2012.06.006_bib0185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/11532310-000000000-00000","article-title":"First, catch your signal!","volume":"33","author":"Edwards","year":"2010","journal-title":"Drug Saf"},{"issue":"15 October (Suppl 1)","key":"10.1016\/j.vaccine.2012.06.006_bib0190","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0264-410X(01)00280-8","article-title":"Statistical assessment of the association between vaccination and rare adverse events post-licensure","volume":"20","author":"Andrews","year":"2001","journal-title":"Vaccine"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2012.06.006_bib0195","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00006454-200104000-00008","article-title":"Population-based study of rotavirus vaccination and intussusception","volume":"20","author":"Kramarz","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2012.06.006_bib0200","first-page":"1180","article-title":"The WHO Programme for International Drug Monitoring, its database, and the technical support of the Uppsala Monitoring Center","volume":"28","author":"Lindquist","year":"2001","journal-title":"J Rheumatol"},{"issue":"July (3)","key":"10.1016\/j.vaccine.2012.06.006_bib0205","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1045-1870(03)00038-4","article-title":"Immunization safety priority project at the World Health Organization","volume":"14","author":"Duclos","year":"2003","journal-title":"Semin Pediatr Infect Dis"},{"issue":"7 May (15\u201316)","key":"10.1016\/j.vaccine.2012.06.006_bib0210","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1016\/j.vaccine.2004.01.016","article-title":"The Brighton Collaboration-enhancing vaccine safety","volume":"22","author":"Bonhoeffer","year":"2004","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12008456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12008456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T18:53:23Z","timestamp":1542912803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12008456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":42,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0264410X12008456"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.06.006","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}